University Hospital
Ghent, Belgium
NCT Number: NCT03339609
Nowadays there is a growing interest towards non-invasive assessment of urinary dysfunctions in clinical practice. The tendency to use uroflowmetry as a first-line screening tool is based on the inexpensiveness, time efficiency, comfort of the patient, etc. However, it is stated that uroflowmetry as a stand-alone study lacks the potential to make an accurate diagnosis. In regard to this, the International Continence Society indicated that the addition of pelvic floor electromyography might increase the accuracy of this assessment. Despite this recommendation, uroflowmetry in combination with electromyography has not been conducted in a healthy population.
The initial objective of this study was to examine whether adding electromyography to standard uroflowmetry in a healthy paediatric population would change the representation of parameters, especially of voiding patterns. In addition, the influence of several factors on uroflow parameters was analysed to complement current literature.
Looking for future studies?
Notify Me5 year–12 year
All sexes
Observational
Ghent, Belgium
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Isolated uroflow measurement
Uroflow measurement with superficial EMG testing of the pelvic floor
Ultrasound of post void residual urine
Time frame: 2017
Interpretation by pediatric urologist
Time frame: 2017
Interpretation using Flow index methodology
Time frame: 2017
Qmax (millilitres/seconds)
Time frame: 2017
millilitres
Time frame: 2017
seconds
Time frame: 2017
millilitres
University Hospital, Ghent
Other
Micturition Reeductation in Children With Cerebral Palsy: Uroflow/EMG Measurement in Healthy Children
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04114266
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Ghent, Belgium
View Trial DetailsNCT02291432
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Miami, Florida, United States
View Trial DetailsNCT03317340
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Scottsdale, Arizona, United States
View Trial DetailsNCT05989646
Behavior, Behavioral Symptoms
Aalborg, Denmark
View Trial Details